Retinoic acid p-hydroxyphenylamide

Fenretinide A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.

Molecular Formula: C₂₆H₃₃NO₂

InChI: InChI=1/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+/f/h27H

InChIKey: InChIKey=AKJHMTWEGVYYSE-IBJYNHCSDK
SMILES: CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C

Names:
    all-trans-4'-Hydroxyretinanilide
    CCRIS 3260
    Fenretinida [Spanish]
    Fenretinide [USAN:INN]
    FENRETINIDE
    Fenretinidum [Latin]
    McN-R-1967
    N-(4-Hydroxyphenyl)retinamide
    Retinoic acid p-hydroxyphenylamide
    (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide
    4-Hydroxyphenyl retinamide

Registries:
    PubChem CID 5288209
    PubChem ID 186933